3Sixty Pharma Solutions LLC
  • Mission
  • Start-Ups
  • Consulting
  • Product Launch & Marketing
  • Clinical Development
  • Case Studies
  • Blog
    • Clinical Trial Financial Management – Live Virtual Training
    • Join us for an interactive webinar!
    • Successful Submission of Start-Up Biotech Investigational New Drug Application
    • “7 Breakthrough Behaviors” at PMI NJ Meeting
    • See You at the Rare Disease Research Symposium 2019
    • 3Sixty Pharma Solutions’ CEO to Speak at the Functional Services CRO Partnerships Conference
    • Exciting News! 3Sixty Pharma Solutions Partners with Westchester Biotech Project
    • Want to apply for NIH funding, but not sure where to start?
    • ‘Thank You’ for Attending ACRP Presentations!
    • Great Conversations at ACRP in Nashville!
    • Innovation in Research 2019: Proud Supporters of Westchester Biotech Project’s March 27 Program
    • Join me for an interactive webinar!
    • Great Conversations at ACRP in Nashville!
    • ‘Thank You’ for Attending ACRP Presentations!
    • Join Us at ACRP in Nashville, April 12-15!
    • Want to apply for NIH funding, but not sure where to start?
    • Risk Management in Device Trials – What You Need to Know
    • In the news: 3Sixty Pharma Solutions CEO & Dartmouth Tuck School of Business
    • Innovation in Research 2019: Proud Supporters of Westchester Biotech Project’s March 27 Program
    • Proud to Support Cutting-Edge Rare Disease Symposium!
    • Great Conversations at BIO in Boston!
    • Working Across Cultures: Minimizing the Impact While Conducting Clinical Trials
    • Strategies & Tactics for Clinical Research Project Management
  • Contact

Melanoma

Jimmy Carter’s Melanoma drug on the verge of ?breakthrough?

Posted on May 18, 2016May 20, 2016 by Admin

In 2014, FDA gave pembrolizumab accelerated approval for melanoma.? Today, the 3-year survival rate in melanoma patients is reported to be 40%.? ASCO president Dr. Julie Vose told NBC News, “This is something really different than what we have seen in the past.” ?nbcnews.to/25btTBv? via @nbcnews? @3SixtyPharma

Posted in Pharma News Tagged 3SixtyPharma, Melanoma Leave a comment

Posts navigation

Recent Posts

  • 2021 Greetings
  • Tips to Quell “Firefighting” in Clinical Research
  • Now Playing on ACRPtv!
  • Clinical Trial Financial Management – Live Virtual Training
  • Join us for an interactive webinar!
  • “7 Breakthrough Behaviors” at PMI NJ Meeting
  • Exciting News! 3Sixty Pharma Solutions Partners with Westchester Biotech Project
  • Join me for an interactive webinar!
  • 3Sixty Pharma Solutions’ CEO to Speak at the Functional Services CRO Partnerships Conference
  • Successful Submission of Start-Up Biotech Investigational New Drug Application
3Sixty Pharma Solutions, LLC
1950 Butler Pike, #175
Conshohocken, PA 19428
contact@3SixtyPharma.com
+1.610.941.4750

©Copyright 3Sixty Pharma Solutions, LLC. 2011-2020. All rights reserved.

 

Loading Comments...